Bioinformatics Analysis of ZBTB16 as a Prognostic Marker for Ewing's Sarcoma
CONCLUSIONS: High expression of ZBTB16 may serve as a predictor biomarker of poor prognosis in ES patients.PMID:34660783 | PMC:PMC8514890 | DOI:10.1155/2021/1989917
Source: Biomed Res - Category: Research Authors: Ke Ding Wenli Qiu Dianbo Yu Huade Ma Kangqi Xie Fuqiang Luo Shanlang Li Zaiyong Li Jihua Wei Source Type: research
More News: Bone Cancers | Databases & Libraries | Ewing's Sarcoma | Genetics | Research | Sarcomas | Study